Clinical decision support
HIMSS23
Stacey Caywood, CEO of Wolters Kluwer Health, discusses how Wolters Kluwer solutions incorporate diversity and inclusivity into the text, images and clinical support sources they provide to help clinicians meet patients’ care needs.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
It is a simple and low-cost model that promotes the early detection of the condition.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
It aims to improve access to diagnostic services in remote areas.
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
HIMSS23
Kathy D. Ford, chief product and strategy officer at Project Rōnin, explains how AI can help drive value-based care for oncology by empowering clinicians to find the most effective, cost-efficient treatment for each patient.
Also, Indian healthcare SaaS platform THB has snapped up $20 million funding.
Also, HeraMED is deploying its remote pregnancy monitoring solutions in a private practice in Perth.
HIMSS23
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.